Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

GlaxoSmithKline, Theravance start Phase III trial of fluticasone furoate/vilanterol to treat COPD By PBR Staff Writer
GlaxoSmithKline and Theravance have started a Phase III efficacy and safety study of a combination treatment of the inhaled corticosteroid (ICS), fluticasone furoate and long-acting beta2agonist (LABA), vilanterol (FF/VI).
Contract Research & Services > Clinical Trials > News
XBiotech announces Phase I/II study results in Lancet Oncology XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, Texas were published in Lancet Oncology.
Contract Research & Services > Clinical Trials > News Agios Pharmaceuticals begins Phase I study of pyruvate kinase deficiency drug By PBR Staff Writer
Agios Pharmaceuticals has announced the dose administration of AG-348, a selective small molecule activator of pyruvate kinase-R (PK-R), in a Phase I study in healthy volunteers for the treatment of pyruvate kinase deficiency.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Microsoft AX for Pharma
With 15 years of experience in both functional and technical modules, Iperion is highly specialised in MS NAV/AX for life sciences and related industries (chemical).
Contract Research & Services > Clinical Trials > Products
‘Meet the Experts’ Day – Childproof Packaging
Faubel invites Dr. Rolf Abelmann, CEO of Institut VerpackungsMarktforschung, to interpack
Contract Research & Services > Clinical Trials > Press Releases
Faubel Showcases Specialist Labelling for the Pharmaceutical and Chemical Industries at Interpack
Every three years, exhibitors at interpack in Düsseldorf present the latest trends from the packaging industry. Among them is Faubel; the international, family-owned company looks forward to welcoming visitors at booth C 15 in hall 7a.
Contract Research & Services > Clinical Trials > Press Releases
GlaxoSmithKline, Theravance start Phase III trial of fluticasone furoate/vilanterol to treat COPD
By PBR Staff Writer
GlaxoSmithKline and Theravance have started a Phase III efficacy and safety study of a combination treatment of the inhaled corticosteroid (ICS), fluticasone furoate and long-acting beta2agonist (LABA), vilanterol (FF/VI).
Contract Research & Services > Clinical Trials > News
XBiotech announces Phase I/II study results in Lancet Oncology
XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, Texas were published in Lancet Oncology.
Contract Research & Services > Clinical Trials > News
Agios Pharmaceuticals begins Phase I study of pyruvate kinase deficiency drug
By PBR Staff Writer
Agios Pharmaceuticals has announced the dose administration of AG-348, a selective small molecule activator of pyruvate kinase-R (PK-R), in a Phase I study in healthy volunteers for the treatment of pyruvate kinase deficiency.
Contract Research & Services > Clinical Trials > News
VentiRx Pharmaceuticals completes patient enrollment in Phase II GOG-3003 study
By PBR Staff Writer
VentiRx Pharmaceuticals has completed the patient enrollment in GOG-3003, a Phase II study of VTX-2337 in combination with pegylated liposomal doxorubicin (PLD) in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer who have failed prior platinum-based chemotherapy.
Contract Research & Services > Clinical Trials > News
Kyowa Hakko begins Phase III trial of asthma drug benralizumab in Japan
By PBR Staff Writer
Japan-based Kyowa Hakko Kirin has started a Calima, one of several trials in the Phase III program for benralizumab, and also plans to initiate Sirocco, another Phase III trial in South Korea.
Contract Research & Services > Clinical Trials > News
Akebia Therapeutics completes enrollment in its Phase IIb clinical study of AKB-6548
Akebia Therapeutics, a biopharmaceutical company, has completed enrollment in its ongoing 200-patient Phase IIb study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.
Contract Research & Services > Clinical Trials > News
CROMSOURCE Expands European Headquarters – Opens New Office Building
CROMSOURCE, an international full service contract research organisation (CRO), today announced the official opening of a new office building in Verona, Italy.
Contract Research & Services > Clinical Trials > Press Releases
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250